|
GTPBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.52890000005135E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.94689999957853E-07 |
| Normal-vs-Stage2 |
8.025000E-04 |
| Normal-vs-Stage3 |
4.180100E-04 |
| Normal-vs-Stage4 |
1.28310000002685E-06 |
| Stage1-vs-Stage2 |
9.057400E-01 |
| Stage1-vs-Stage3 |
8.248200E-01 |
| Stage1-vs-Stage4 |
9.760300E-02 |
| Stage2-vs-Stage3 |
7.849600E-01 |
| Stage2-vs-Stage4 |
9.411900E-02 |
| Stage3-vs-Stage4 |
1.577050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.11370000017197E-07 |
| Normal-vs-AfricanAmerican |
4.23179999997636E-06 |
| Normal-vs-Asian |
1.02140000002304E-06 |
| Caucasian-vs-AfricanAmerican |
6.848000E-01 |
| Caucasian-vs-Asian |
7.439500E-02 |
| AfricanAmerican-vs-Asian |
6.515700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.84249999987973E-07 |
| Normal-vs-Female |
3.448200E-04 |
| Male-vs-Female |
7.631200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.48299999969926E-07 |
| Normal-vs-Extreme_Weight |
1.8061499999944E-05 |
| Normal-vs-Obese |
5.623000E-03 |
| Normal-vs-Extreme_Obese |
1.239270E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.782800E-01 |
| Normal_Weight-vs-Obese |
2.614300E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.884800E-01 |
| Extreme_Weight-vs-Obese |
1.802980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.456400E-01 |
| Obese-vs-Extreme_Obese |
1.879020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.552000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.757200E-04 |
| Normal-vs-Age(61-80Yrs) |
4.02780000463565E-08 |
| Normal-vs-Age(81-100Yrs) |
3.789999999948E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.975600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.149600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.171760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.680100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.576300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.106800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.367200E-04 |
| Normal-VS-Type2 PRCC |
3.25980353821365E-11 |
| Normal-VS-KIRP CIMP |
9.744000E-02 |
| Normal-VS-Unclassified PRCC |
6.998800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.25250000038157E-07 |
| Type1 PRCC-VS-KIRP CIMP |
8.384800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.638400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.635100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.380000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.498800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48190000270887E-08 |
| Normal-vs-N1 |
8.804700E-04 |
| Normal-vs-N2 |
2.738200E-01 |
| N0-vs-N1 |
4.545200E-01 |
| N0-vs-N2 |
1.128390E-01 |
| N1-vs-N2 |
3.598800E-01 |
|
|
